| View |
Valsartan + Hydrochlorothiazide
|
320 mg/25 mg
|
Film-Coated Tablet
|
|
| View |
Valsartan + Hydrochlorothiazide
|
80 mg/12.5 mg
|
Film-Coated Tablet
|
|
| View |
Basiliximab
|
20 mg
|
Powder for IV injection
|
|
| View |
Ciclosporin
|
100 mg
|
Softgel Capsule
|
|
| View |
Ciclosporin
|
25 mg
|
Softgel Capsule
|
|
| View |
Ciclosporin
|
100 mg/ml
|
Oral Solution
|
|
| View |
Ciclosporin
|
25 mg
|
Softgel capsule
|
|
| View |
Ciclosporin
|
100 mg
|
Softgel capsule
|
|
| View |
Epoetin Alfa
|
10,000 IU/mL
|
Solution for Injection (IV/SC)
|
|
| View |
Epoetin Alfa
|
4,000 IU/0.4mL
|
Solution for Injection (IV/SC)
|
|
| View |
Epoetin Alfa
|
40,000 IU/mL
|
Solution for Injection (IV/SC)
|
|
| View |
Mycophenolic Acid
|
360 mg
|
Film-Coated Tablet (gastro resistant)
|
|
| View |
Sevelamer Carbonate
|
800 mg
|
Powder for Oral Suspension
|
|
| View |
Terlipressin
|
1mg
|
Powder and solvent for solution for injection (IV Bolus Injection)
|
|
| View |
Everolimus
|
250 mcg
|
Tablet
|
|
| View |
Everolimus
|
500 mcg
|
Tablet
|
|
| View |
Recombinant Human Erythropoietin Alfa
|
4000 IU/0.4 mL
|
Solution for Injection (IV/SC)
|
|
| View |
Hemofiltration Solution
|
Sodium Chloride 6.136 g Sodium Hydrogen Carbonate 2.940 g Calcium Chloride Dihydrate 220.5 mg Magnesium Chloride Hexahydrate 101.7 mg Glucose Monohydrate (equivalent to anhydrous glucose 1.000 g) 1.100 g
|
Solution for Hemofiltration (I.V.)
|
|
| View |
Peritoneal Dialysis Solution with 1.5% Dextrose
|
Calcium Chloride Dihydrate 257.3 mg Sodium Chloride 5.786 g Sodium (S) Lactate Solution (Containing sodium (S) lactate 3.925 g) 7.85 g Magnesium Chloride Hexahydrate 101.7 mg Dextrose (as anhydrous glucose 15 g) 16.5 g
|
Solution for Intraperitoneal Administration
|
|
| View |
Peritoneal Dialysis Solution with 1.5% Dextrose
|
Dextrose (as anhydrous glucose 15 g) 16.5 g
Sodium (S) Lactate Solution [(Containing sodium (S) lactate 3.925 g) 7.85 g, Sodium Chloride 5.786 g, Calcium Chloride Dihydrate 183.8 mg, Magnesium Chloride Hexahydrate 101.7 mg]
|
Solution for Intraperitoneal Administration
|
|